Luca Testa, MD, PhD

Original Contribution

Outcome of Patients Undergoing Transcatheter Aortic Valve Implantation After Prior Balloon Aortic Valvuloplasty

09/27/2018

Francesco Bedogni , MD, PhD;

Arturo Giordano , MD, PhD;

Nicola Corcione , MD;

Paolo Ferraro , MD;

Gennaro Sardella , MD, PhD;

Massimo Mancone , MD, PhD;

Fabrizio Tomai , MD;

Giovanni De Persio , MD;

Giacomo Frati , MD, MSc;

Giuseppe G.L. Biondi-Zoccai , MD, PhD;

Luca Testa , MD, PhD;

Alessandro Iadanza , MD;

We aimed to determine whether prior balloon aortic valvuloplasty would unfavorably impact transcatheter aortic valve implantation. Outcomes of interest were procedural results, hospital stay, and in-hospital outcomes, including major adverse...

We aimed to determine whether...

09/27/2018

Journal of Invasive Cardiology

Original Contribution

Valve-in-Valve Implantation of Medtronic CoreValve Prosthesis in Patients With Failing Bioprosthetic Aortic Valves: Mid-term Outcomes From the Italian CoreValve Clinical Service Project

01/30/2022

Antonio Mangieri , MD;

Francesco Bedogni , MD, PhD;

Marco Barbanti , MD;

Corrado Tamburino , MD, PhD, FESC, FSCAI;

Antonio Colombo , MD;

Luca Testa , MD, PhD;

Alessandro Iadanza , MD;

Massimo Fineschi , MD;

Giuseppe Bruschi , MD, PhD;

Arnaldo Poli , MD;

Matteo Montorfano , MD;

Diego Maffeo , MD;

Arif A. Khokhar , BM, BCh;

Anna Sonia Petronio , MD;

Cristina Giannini , MD;

Marco Angelillis , MD;

Claudia Fiorina , MD;

Marianna Adamo , MD;

Salvatore Curello , MD;

We evaluated the acute and two-year safety and efficacy of using the CoreValve, Evolut R, and Evolut PRO valves for treating failed surgical bioprosthesis from the Italian CoreValve Clinical Service Project.

We evaluated the acute and...

01/30/2022

Journal of Invasive Cardiology

Comparing the Safety and Effectiveness of Five Leading New-Generation Devices for Transcatheter Aortic Valve Implantation: Twelve-Month Results From the RISPEVA Study

05/01/2021

Martino Pepe , MD, PhD;

Alberto Morello , MD;

Antonio L. Bartorelli , MD;

Carmen Spaccarotella , MD;

Michele Cimmino , MD;

Anna Sonia Petronio , MD;

Luca Testa , MD, PhD;

Maurizio Tespili , MD;

Alessandro Iadanza , MD;

Arturo Giordano , MD, PhD;

Nicola Corcione , MD;

Paolo Ferraro , MD;

Giacomo Frati , MD, MSc;

Giuseppe G.L. Biondi-Zoccai , MD, PhD;

Sergio Berti , MD;

Enrico Romagnoli , MD, PhD;

Damiano Regazzoli , MD;

To learn more about the comparative effectiveness and safety of contemporary TAVI devices, we queried data from the national Italian TAVI registry comparing features, procedural details, and 12-month outcomes of Acurate Neo, Evolut Pro/R,...

To learn more about the...

05/01/2021

Journal of Invasive Cardiology

Paclitaxel DCB 12-Month PREVAIL Study Results Figure 1

Original Contribution

Paclitaxel Drug-Coated Balloon for the Treatment of De Novo Small-Vessel and Restenotic Coronary Artery Lesions: 12-Month Results of the Prospective, Multicenter, Single-Arm PREVAIL Study

11/01/2021

Cheryl Shen , MS;

Gwenn Wetzels , PhD;

Luca Testa , MD, PhD;

Joseph "Jo" Dens , MD, PhD;

Mark S. Patterson , MBBS, PhD, MD, MRCP;

Azeem Latib , MD, BCh, MBBCh;

Patrizio Lancellotti , MD, PhD;

Pierfrancesco Agostoni , MD, PhD;

Frankie C.C. Tam , MD;

Carl Schotborgh , MD;

Elvin Kedhi , MD;

Pieter R. Stella , MD, PhD;

The PREVAIL study evaluated the safety and effectiveness of a paclitaxel DCB for the treatment of coronary de novo and ISR lesions in patients with symptomatic ischemic heart disease.

The PREVAIL study evaluated the...

11/01/2021

Journal of Invasive Cardiology

Original Contribution

No-Reflow Complicating Chronic Total Occlusion Coronary Revascularization

01/31/2020

Luca Testa , MD, PhD;

Gianni Dall'Ara , MD;

Carlo Di Mario , MD, PhD, FESC, FACC, FRCP;

Carlo Tumscitz , MD;

Simone Grotti , MD;

Alessio Mattesini , MD;

Fabio Tarantino , MD;

Mario Bollati , MD;

Jacopo A. Oreglia , MD;

Gabriele Luigi Gasparini , MD;

Our objectives were to assess the incidence of no-reflow in patients undergoing CTO-PCI, to analyze possible causes and differential diagnoses, and to identify useful management approaches. We reviewed no-reflow complications in this...

Our objectives were to assess...

01/31/2020

Journal of Invasive Cardiology